Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001308
Filing Date
2024-08-12
Accepted
2024-08-12 16:01:47
Documents
60
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atxs-20240630x10q.htm   iXBRL 10-Q 1258736
2 EX-10.1 atxs-20240630xex10d1.htm EX-10.1 99227
3 EX-31.1 atxs-20240630xex31d1.htm EX-31.1 11212
4 EX-31.2 atxs-20240630xex31d2.htm EX-31.2 11190
5 EX-32.1 atxs-20240630xex32d1.htm EX-32.1 6264
  Complete submission text file 0001410578-24-001308.txt   5541629

Data Files

Seq Description Document Type Size
6 EX-101.SCH atxs-20240630.xsd EX-101.SCH 35236
7 EX-101.CAL atxs-20240630_cal.xml EX-101.CAL 41342
8 EX-101.DEF atxs-20240630_def.xml EX-101.DEF 152991
9 EX-101.LAB atxs-20240630_lab.xml EX-101.LAB 356258
10 EX-101.PRE atxs-20240630_pre.xml EX-101.PRE 244568
63 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20240630x10q_htm.xml XML 892951
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 241196645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)